Profile data is unavailable for this security.
About the company
AVE Science & Technology Co Ltd is a China-based company principally engaged in the research and development, production, sales and service of medical clinical laboratory analysis instruments and supporting in vitro diagnostic reagents and medical consumables. The Company’s main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables and other products. The Company's products are mainly used in inspection departments of various medical and health institutions. The Company distributes its products both in the domestic market and to overseas markets.
- Revenue in CNY (TTM)202.67m
- Net income in CNY22.56m
- Incorporated2000
- Employees492.00
- LocationAVE Science & Technology Co LtdAVE Medical Technology Park, No. 26Fuling Road, Xueshi Neighborhood, YueluCHANGSHA 410208ChinaCHN
- Phone+86 73 189715453
- Fax+86 73 188907046
- Websitehttp://www.c-ave.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Rightongene Biotechnlgy Co Ltd | 249.02m | -5.17m | 1.21bn | 501.00 | -- | 1.28 | -- | 4.84 | -0.0877 | -0.0877 | 4.43 | 16.87 | 0.2384 | 1.20 | 1.32 | 497,050.10 | -1.37 | 4.16 | -1.46 | 4.49 | 72.98 | 70.45 | -5.75 | 11.62 | 11.12 | -- | 0.025 | 5.90 | -39.14 | 2.84 | -80.41 | -11.46 | 19.65 | -- |
| AVE Science & Technology Co Ltd | 202.67m | 22.56m | 1.22bn | 492.00 | 54.17 | 2.45 | -- | 6.03 | 0.3318 | 0.3318 | 2.98 | 7.35 | 0.3683 | 1.93 | 30.00 | 411,925.30 | 4.10 | 7.21 | 4.46 | 8.18 | 56.73 | 58.93 | 11.13 | 15.48 | 5.51 | -- | 0.00 | 22.46 | 1.79 | 5.88 | 19.81 | -4.62 | -23.68 | -- |
| Jiangsu Nanfang Medical Co Ltd | 584.85m | -167.99m | 1.29bn | 858.00 | -- | 2.83 | -- | 2.21 | -0.5812 | -0.5812 | 2.02 | 1.58 | 0.4294 | 1.86 | 3.49 | 681,641.10 | -12.31 | -1.09 | -28.91 | -2.00 | 5.64 | 20.14 | -28.66 | -1.91 | 0.3748 | -9.58 | 0.5314 | -- | 10.03 | 4.57 | -906.35 | -- | -3.18 | -- |
| Suzhou Iron Technology Co Ltd | 323.32m | -43.37m | 1.30bn | 680.00 | -- | 1.73 | -- | 4.01 | -0.5716 | -0.5716 | 4.24 | 9.72 | 0.2343 | 1.93 | 1.18 | 475,466.10 | -3.40 | 7.11 | -5.48 | 10.56 | 46.24 | 56.00 | -14.52 | 19.17 | 1.23 | -4.90 | 0.2571 | 25.00 | -23.84 | 8.73 | -71.17 | -10.40 | 36.50 | -- |
| CareRay Digital Medical Technology CoLtd | 287.84m | 24.70m | 1.32bn | 252.00 | 54.18 | 1.55 | -- | 4.59 | 0.2769 | 0.2769 | 3.22 | 9.69 | 0.3062 | 1.60 | 3.92 | 1,142,221.00 | 2.62 | 6.65 | 2.85 | 7.37 | 42.76 | 41.17 | 8.55 | 15.64 | 6.76 | -- | 0.0224 | 27.61 | 33.81 | 5.17 | 374.05 | -20.74 | 77.38 | -- |
| Touchstone International Medi Sci Co Ltd | 274.03m | 56.95m | 1.53bn | 243.00 | 25.73 | 2.67 | -- | 5.57 | 0.731 | 0.731 | 3.51 | 7.05 | 0.4352 | 3.16 | 18.94 | 1,127,699.00 | 9.05 | 10.09 | 10.06 | 10.82 | 55.96 | 57.59 | 20.78 | 20.17 | 4.76 | -- | 0.0028 | 24.66 | 9.31 | 16.34 | 9.53 | 15.39 | -2.39 | -- |
| Thalys Medical Technology Group Corp | 1.90bn | -210.78m | 1.65bn | 1.41k | -- | 1.55 | -- | 0.8715 | -1.36 | -1.36 | 11.68 | 5.31 | 0.5508 | 4.16 | 1.22 | 1,349,051.00 | -6.04 | -0.8933 | -11.27 | -1.62 | 18.51 | 22.12 | -10.97 | -1.49 | 1.43 | -0.9666 | 0.4974 | -- | -13.10 | 8.77 | -2.69 | -- | -19.20 | -- |
| Shanghai Rendu Biotechnology Co Ltd | 177.96m | 21.27m | 1.67bn | 358.00 | 78.73 | 1.81 | -- | 9.41 | 0.5318 | 0.5318 | 4.45 | 23.18 | 0.1734 | 1.29 | 2.41 | 497,088.50 | 2.07 | 6.26 | 2.22 | 7.17 | 79.87 | 74.36 | 11.95 | 14.54 | 12.02 | -- | 0.0052 | 7.96 | -45.89 | 18.85 | -64.60 | -- | 23.48 | -- |
Data as of Nov 15 2024. Currency figures normalised to AVE Science & Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.95%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2024 | 194.53k | 1.41% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2024 | 97.78k | 0.71% |
| Gfund Management Co., Ltd.as of 30 Jun 2024 | 72.66k | 0.53% |
| Fortune & Royal Asset Management Co., Ltd.as of 30 Jun 2024 | 15.50k | 0.11% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2024 | 10.99k | 0.08% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 8.85k | 0.06% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 4.00k | 0.03% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 2.90k | 0.02% |
| Golden Eagle Asset Management Co., Ltd.as of 30 Jun 2024 | 1.26k | 0.01% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2024 | 208.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
